Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;12(1):141-146.
doi: 10.3892/etm.2016.3266. Epub 2016 Apr 19.

Experimental study of USPIO-enhanced MRI in the detection of atherosclerotic plaque and the intervention of atorvastatin

Affiliations

Experimental study of USPIO-enhanced MRI in the detection of atherosclerotic plaque and the intervention of atorvastatin

Ting Sha et al. Exp Ther Med. 2016 Jul.

Abstract

Ultrasmall superparamagnetic iron oxide (USPIO) can identify atherosclerotic vulnerable plaque and atorvastatin can stabilize vulnerable plaque by inhibiting the inflammatory response. Using balloon injury in rabbit abdominal aortic endothelial cells and p53 gene transfecting the local plaque, we established an atherosclerotic vulnerable plaque model. In the treatment group, animals were treated with atorvastatin for 8 weeks. At the end of week 16, the animals in each group underwent medication trigger. USPIO-enhanced MRI was utilized to detect vulnerable plaque formation and the transformation of stable plaque in the treatment group. Pathological and serological studies were conducted in animal sera and tissues. The images from the USPIO-enhanced MRI, and the vulnerable plaque showed low signal, especially on T2*-weighted sequences (T2*WI). Plaque signal strength reached a negative enhancement peak at 96 h. Compared with the other groups, lipids, cell adhesion molecule-1 and vascular cell adhesion molecule-1 levels were significantly lower (P<0.05) in the treatment group. In conclusion, USPIO-enhanced MRI can identify vulnerable plaque formation by deposition in macrophages, while atorvastatin is able to inhibit the progression of atherosclerosis and promote plaque transformation to the stable form.

Keywords: atherosclerotic plaque; cell adhesion molecule-1; superparamagnetic iron oxide.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The intensity change of plaque signals in 3 groups after USPIO particle enhancement. USPIO, ultrasmall superparamagnetic iron oxide.
Figure 2.
Figure 2.
Comparison of SNR. Comparison of the SNR change before its enhancement at 96 h after enhancement, the negative enhancement of plaque signals in group B peaked. By contrast, the changes in groups A and C showed no statistical difference, indicating that the nature and composition of plaques did not change significantly. SNR, signal-to-noise ratio.
Figure 3.
Figure 3.
(A) Group B significantly reduced lumen, the lumen uniform group C.
Figure 4.
Figure 4.
Group B, substantial foam cell proliferation. The collagen proliferation was not obvious in the 3 groups.
Figure 5.
Figure 5.
(A) The control group (×100) showed no particle deposition or (C) (×100) visible macrophage USPIO particle deposition, and was (B) the same at high magnification (×200). USPIO, ultrasmall superparamagnetic iron oxide.
Figure 6.
Figure 6.
Electron microscopy. (A) Increased lysosomes, (B) foam cell proliferation with visible lipid droplets. (C) Iron particle deposition inside macrophages.

Similar articles

Cited by

References

    1. Virani SS, Polsani VR, Nambi V. Novel markers of infam-mation in atherosclerosis. Curr Atheroscler Rep. 2008;10:164–170. doi: 10.1007/s11883-008-0024-0. - DOI - PubMed
    1. Kleemann R, Zadelaar S, Kooistra T. Cytokines and athero-sclerosis: A comprehensive review of studies in mice. Cardiovasc Res. 2008;79:360–376. doi: 10.1093/cvr/cvn120. - DOI - PMC - PubMed
    1. Wang HD, Yu SQ, Gao F, Qin ML. The anti-atherosclerosiseffect of adiponectin. Chongqing Med J. 2009;38:2509–2510. (In Chinese)
    1. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2002;102:2165–2168. doi: 10.1161/01.CIR.102.18.2165. - DOI - PubMed
    1. Beck B, Weintraub W, Alexander R. Elevation of C-reactive protein in ‘active’ coronary artery disease. AMJ Cardiol. 1990;65:168–172. doi: 10.1016/0002-9149(90)90079-G. - DOI - PubMed

LinkOut - more resources